-
1 Comment
Xiamen Kingdomway Group Company is currently in a long term uptrend where the price is trading 4.9% above its 200 day moving average.
From a valuation standpoint, the stock is 27.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.0.
Xiamen Kingdomway Group Company's total revenue rose by 4.5% to $936M since the same quarter in the previous year.
Its net income has increased by 313.2% to $165M since the same quarter in the previous year.
Finally, its free cash flow fell by 17.5% to $158M since the same quarter in the previous year.
Based on the above factors, Xiamen Kingdomway Group Company gets an overall score of 4/5.
| ISIN | CNE1000018X4 |
|---|---|
| Industry | Packaged Foods |
| Sector | Consumer Defensive |
| CurrencyCode | CNY |
| Exchange | SHE |
| Target Price | 34 |
|---|---|
| Dividend Yield | 2.6% |
| PE Ratio | 31.66 |
| Market Cap | 15B |
| Beta | 1.01 |
Xiamen Kingdomway Group Company engages in the manufacturing and sale of the nutrition and health resources in China and internationally. It offers a series of raw material products, including coenzyme Q10, Vitamin A, Vitamin D3, microalgae DHA, and plant ARA, as well as provides dietary supplements and sports nutrition products. The company was formerly known as Xiamen Jindawei Vitamin Co., Ltd. Xiamen Kingdomway Group Company was founded in 1997 and is based in Xiamen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002626.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
